
    
      The study is a randomized double-blind, placebo-controlled trial, designed to evaluate the
      efficacy of intravenous [21CFR640.30] Plasma from young, volunteer donors between the ages of
      18 - 25 years (yFFP - young Fresh Frozen Plasma) at 12.5 ml/kg in each of two doses, one day
      apart (25 ml/kg total).
    
  